Intestinal inflammatory biomarkers and outcome in pediatric clostridium difficile infections

Journal of Pediatrics

Volumn 163, Issue 6, 2013, Pages

  El Feghaly, Rana E ^a   Stauber, Jennifer L ^a   Tarr, Phillip I ^a   Haslam, David B ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BIOLOGICAL MARKER; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 8; LACTOFERRIN; MESSENGER RNA; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; SYNAPTOPHYSIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; ASYMPTOMATIC INFECTION; BACTERIAL COLONIZATION; BACTERIAL LOAD; CHILD; CHILDHOOD DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; CONCURRENT INFECTION; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME IMMUNOASSAY; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERSISTENT INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RNA TRANSCRIPTION; SCHOOL CHILD; SENSITIVITY ANALYSIS; VIRAL GASTROENTERITIS;

EID: 84888325292     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.07.029     Document Type: Article

References (44)

1. C.P. Kelly, and J.T. LaMont Clostridium difficile - more difficult than ever N Engl J Med 359 2008 1932 1940
2. D.M. Denno, N. Shaikh, J.R. Stapp, X. Qin, C.M. Hutter, and V. Hoffman Diarrhea etiology in a pediatric emergency department: a case control study Clin Infect Dis 55 2012 897 904
3. C.M. Thompson Jr., P.H. Gilligan, M.C. Fisher, and S.S. Long Clostridium difficile cytotoxin in a pediatric population Am J Dis Child 137 1983 271 274
4. I.J. Al-Jumaili, M. Shibley, A.H. Lishman, and C.O. Record Incidence and origin of Clostridium difficile in neonates J Clin Microbiol 19 1984 77 78
5. K. Bryant, and L.C. McDonald Clostridium difficile infections in children Pediatr Infect Dis J 28 2009 145 146
6. C. Rousseau, I. Poilane, L. De Pontual, A.C. Maherault, A. Le Monnier, and A. Collignon Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains Clin Infect Dis 55 2012 1209 1215
7. Centers for Disease Control and Prevention Severe Clostridium difficile-associated disease in populations previously at low risk - four states, 2005 MMWR Morb Mortal Wkly Rep 54 2005 1201 1205
8. J. Kim, S.A. Smathers, P. Prasad, K.H. Leckerman, S. Coffin, and T. Zaoutis Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006 Pediatrics 122 2008 1266 1270
9. J.S. Sammons, P. Toltzis, and T.E. Zaoutis Clostridium difficile infection in children JAMA Pediatr 167 2013 567 573
10. M.H. Wilcox, L. Mooney, R. Bendall, C.D. Settle, and W.N. Fawley A case-control study of community-associated Clostridium difficile infection J Antimicrob Chemother 62 2008 388 396
11. M.B. Cohen Clostridium difficile infections: emerging epidemiology and new treatments J Pediatr Gastroenterol Nutr 48 Suppl 2 2009 S63 S65
12. L. Benson, X. Song, J. Campos, and N. Singh Changing epidemiology of Clostridium difficile-associated disease in children Infect Control Hosp Epidemiol 28 2007 1233 1235
13. M.D. Zilberberg, G.S. Tillotson, and C. McDonald Clostridium difficile infections among hospitalized children, United States, 1997-2006 Emerg Infect Dis 16 2010 604 609
14. S. Khanna, L.M. Baddour, W.C. Huskins, P.P. Kammer, W.A. Faubion, and A.R. Zinsmeister The epidemiology of Clostridium difficile infection in children: a population-based study Clin Infect Dis 56 2013 1401 1406
15. C.M. Nylund, A. Goudie, J.M. Garza, G. Fairbrother, and M.B. Cohen Clostridium difficile infection in hospitalized children in the United States Arch Pediatr Adolesc Med 165 2011 451 457
16. J.S. Sammons, R. Localio, R. Xiao, S.E. Coffin, and T. Zaoutis Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children Clin Infect Dis 57 2013 1 8
17. S. Jangi, and J.T. Lamont Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life J Pediatr Gastroenterol Nutr 51 2010 2 7
18. R. Madan, and W.A. Jr Immune responses to Clostridium difficile infection Trends in molecular medicine 18 2012 658 666
19. L.D. Bobo, R.E. El Feghaly, Y.S. Chen, E.R. Dubberke, Z. Han, and A. Baker MK2 Kinase Contributes to Clostridium difficile-associated inflammation Infect Immun 81 2013 713 722
20. S. Pai, S.H. Aliyu, D.A. Enoch, and J.A. Karas Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management PloS One 7 2012 e51728
21. G.E. Schutze, R.E. Willoughby, Committee on Infectious Diseases, and American Academy of Pediatrics Clostridium difficile infection in infants and children Pediatrics 131 2013 196 200
22. J. Belmares, D.N. Gerding, J.P. Parada, S. Miskevics, F. Weaver, and S. Johnson Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system J Infect 55 2007 495 501
23. S. Fujitani, W.L. George, and A.R. Murthy Comparison of clinical severity score indices for Clostridium difficile infection Infect Control Hosp Epidemiol 32 2011 220 228
24. D.N. Gerding, and S. Johnson Does infection with Specific Clostridium difficile strains or clades influence clinical outcome Clin Infect Dis 56 2013 1601 1603
25. S.T. Walk, D. Micic, R. Jain, E.S. Lo, I. Trivedi, and E.W. Liu Clostridium difficile ribotype does not predict severe infection Clin Infect Dis 55 2012 1661 1668
26. A.S. Walker, D.W. Eyre, D.H. Wyllie, K.E. Dingle, D. Griffiths, and B. Shine Relationship between bacterial strain type, host biomarkers and mortality in Clostridium difficile infection Clin Infect Dis 56 2013 1589 1600
27. R.E. El Feghaly, J.L. Stauber, E. Deych, C. Gonzalez, P.I. Tarr, and D.B. Haslam Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection Clin Infect Dis 56 2013 1713 1721
28. M.B. Yacyshyn, and B. Yacyshyn The role of gut inflammation in recurrent CDAD Clin Infect Dis 56 2013 1722 1723
29. X. Qin, Y. Razia, J.R. Johnson, J.R. Stapp, D.R. Boster, and T. Tsosie Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children Antimicrob Agents Chemother 50 2006 3325 3329
30. S.J. Lewis, and K.W. Heaton Stool form scale as a useful guide to intestinal transit time Scand J Gastroenterol 32 1997 920 924
31. D. Wroblewski, G.E. Hannett, D.J. Bopp, G.K. Dumyati, T.A. Halse, and N.B. Dumas Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens J Clin Microbiol 47 2009 2142 2148
32. L. Grant, J. Vinje, U. Parashar, J. Watt, R. Reid, and R. Weatherholtz Epidemiologic and clinical features of other enteric viruses associated with acute gastroenteritis in American Indian infants J Pediatr 161 2012 110 115.e1
33. M.M. Freeman, T. Kerin, J. Hull, K. McCaustland, and J. Gentsch Enhancement of detection and quantification of rotavirus in stool using a modified real-time RT-PCR assay J Med Virol 80 2008 1489 1496
34. C.C. Chen, C.J. Chang, T.Y. Lin, M.W. Lai, H.C. Chao, and M.S. Kong Usefulness of fecal lactoferrin in predicting and monitoring the clinical severity of infectious diarrhea World J Gastroenterol 17 2011 4218 4224
35. T.A. Judd, A.S. Day, D.A. Lemberg, D. Turner, and S.T. Leach Update of fecal markers of inflammation in inflammatory bowel disease J Gastroenterol Hepatol 26 2011 1493 1499
36. K. Z'Graggen, A. Walz, L. Mazzucchelli, R.M. Strieter, and C. Mueller The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease Gastroenterology 113 1997 808 816
37. H. Kim, E. Kokkotou, X. Na, S.H. Rhee, M.P. Moyer, and C. Pothoulakis Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase Gastroenterology 129 2005 1875 1888
38. J.Y. Lee, H.R. Park, Y.K. Oh, Y.J. Kim, J. Youn, and J.S. Han Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A J Mol Med (Berl) 85 2007 1393 1404
39. R. Eglow, C. Pothoulakis, S. Itzkowitz, E.J. Israel, C.J. O'Keane, and D. Gong Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor J Clin Invest 90 1992 822 829
40. S.H. Cohen, D.N. Gerding, S. Johnson, C.P. Kelly, V.G. Loo, and L.C. McDonald Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
41. V.G. Loo, A.M. Bourgault, L. Poirier, F. Lamothe, S. Michaud, and N. Turgeon Host and pathogen factors for Clostridium difficile infection and colonization N Engl J Med 365 2011 1693 1703
42. M. Miller, D. Gravel, M. Mulvey, G. Taylor, D. Boyd, and A. Simor Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality Clin Infect Dis 50 2010 194 201
43. F. Barbut, and M. Rupnik Editorial commentary: 027, 078, and others: going beyond the numbers (and away from the hypervirulence) Clin Infect Dis 55 2012 1669 1672
44. L.C. McDonald Virulence and clinical outcomes in Clostridium difficile Infection: a complex business Clin Infect Dis 56 2013 906 907